• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Repros Therapeutics Inc. (RPRX)

    -NasdaqCM
    9.21 Down 0.28(2.95%) Feb 27, 4:00PM EST
    |After Hours : 9.22 Up 0.01 (0.06%) Feb 27, 4:32PM EST
    Add to Portfolio
    Prev Close:9.49
    Open:9.55
    Bid:8.89 x 500
    Ask:N/A
    1y Target Est:28.20
    Beta:-1.05
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:9.05 - 9.60
    52wk Range:5.92 - 22.55
    Volume:182,752
    Avg Vol (3m):419,303
    Market Cap:223.58M
    P/E (ttm):N/A
    EPS (ttm):-1.37
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    RPRXDown 2.95%223.58M
    ABTDown 0.50%71.33B
    ACTUp 0.55%77.58B
    AUXL 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.42
    Quarterly EPS Est (Dec-14) :-0.34
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):0.31

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Repros Therapeutics Inc., a development stage biopharmaceutical company, focuses on the development of new drugs to treat hormonal and reproductive system disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback